2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Competitive Strategies

2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Compet

Category : Diagnostic and Biotech
Published On : November  2014
Pages : 973



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

2014-2018 US Critical Care Diagnostic Testing in Ancillary Hospital Locations (ER, OR, ICU): Volume and Sales Forecasts, Emerging Technologies, Competitive Strategies.

This 973-page report contains 153 tables and provides comprehensive analysis of the diagnostic testing markets outside the main hospital laboratory (ERs, ORs, and ICUs). The report includes analysis of the market dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. We trust, this report will help diagnostic products suppliers develop more effective business, R&D and marketing strategies.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals closer to the patient.

Market Segmentation Analysis

Review of the ER, OR and ICU market segments, including their dynamics, trends, structure, size, growth and major suppliers.
Five-year test volume and sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment:
Emergency Rooms
Operating/Recovery Suites
ICUs/CCUs and test category:
Routine and Special Chemistry
Microbiology/Infectious Diseases
Hematology
Flow Cytometry
Coagulation
Immunoproteins
Drugs of Abuse
TDM
Endocrine Function
Tumor Markers
Sales and Market Share Analysis

Sales and market shares of major reagent and instrument suppliers.

Current and Emerging Products

Analysis of over 130 diagnostic procedures.
Review of leading POC chemistry, immunoassay, hematology and coagulation analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices.
Technology Review

Emerging technologies and their applications for POC testing.
Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.
Competitive Assessments

Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next ten years.
Design criteria for POC testing products.
Alternative business expansion strategies.
Potential market entry barriers and risks.
Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and Venture Planning Group’s proprietary data files.

image
Can't read the image ? refresh here.


Enquiry Before Buy
image
Can´t read the image ? refresh here.